Download - Berlin School of Mind and Brain
Download - Berlin School of Mind and Brain
Download - Berlin School of Mind and Brain
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Barbara Trattner<br />
Optogenetics<br />
Optogenetics is an elegant emerging method in neuroscience, which exploits optical <strong>and</strong><br />
genetic tools to precisely control neuronal brain circuits in living animals at a high<br />
temporal <strong>and</strong> spatial resolution. Generally neuronal properties are investigated with the<br />
help <strong>of</strong> selective pharmacological agents targeting certain neuronal structures. These<br />
agents are however disadvantageous in that they have a systemic action, are temporally<br />
imprecise <strong>and</strong> may cause unspecific side-effects. In addition to replacing pharmacology,<br />
optogenetic approaches can also substitute electrical stimulation <strong>of</strong> a neuronal population<br />
for defined light-gated activation. Photosensitive proteins can be artificially expressed in<br />
neurones to alter their firing properties <strong>and</strong> thereby information processing. By exposing<br />
only a certain brain area to light, only the activity <strong>of</strong> those neurones will be modulated by<br />
the photosensitive proteins. Due to the immense possibilities that optogenetics <strong>of</strong>fer in<br />
elucidating neuronal brain circuits, it was selected the method <strong>of</strong> the year 2010 by the<br />
prestigious scientific journal Nature Methods. The principle <strong>of</strong> using optogenetics was<br />
first found around 2000, when photosensitive proteins were expressed in neurones, which<br />
could thereby be sensitised to light. Further research in the field <strong>of</strong> optogenetics led to the<br />
implementation <strong>of</strong> genetically-encoded bacterial <strong>and</strong> algeal photosensitive ion channels<br />
<strong>and</strong> pumps in neurones. Depending on the properties <strong>of</strong> these ion transporters, they can<br />
either hyperpolarise or depolarise neurones. An advantage <strong>of</strong> using photosensitive ion<br />
transporters to targeting endogenous channels with drugs is the fast time constant: Upon<br />
illumination with the correct wavelength, photosensitive channels open <strong>and</strong> close in the<br />
range <strong>of</strong> milliseconds. A lot <strong>of</strong> research is currently going on to develop new artificial<br />
light-gated ion channels or receptors. With the help <strong>of</strong> tissue-specific promoters, these<br />
proteins can be expressed only in a certain neuronal subgroup or at a confined<br />
developmental stage.<br />
Precisely choosing the brain area, which is exposed to light, allows the further refinement<br />
<strong>of</strong> the subgroup <strong>of</strong> modulated neurones. By expressing photosensitive proteins in a<br />
subclass <strong>of</strong> neurones responsible for a defined behaviour, researchers can nowadays<br />
control behaviour by exciting or inhibiting only those neurones with light. Flies for<br />
instance can learn that a certain odour is aversive when the odour is paired with the lightgated<br />
activation <strong>of</strong> a certain receptor class. Mice can be woken up when a certain neuronal<br />
population <strong>of</strong> the hypothalamus, artificially expressing photosensitive proteins, are<br />
stimulated with light.<br />
The therapeutic aim <strong>of</strong> optogenetics for humans is to restore vision after a degeneration <strong>of</strong><br />
photoreceptor cells in the retina. In mice it was shown that equipping retinal neurones<br />
with photosensitive proteins from microbes using a viral delivery can restore visual<br />
responses. In humans this approach is currently investigated in inherited retinal<br />
dysfunctions: In Leber’s congenital amaurosis patient lack a certain pigment protein <strong>of</strong><br />
the retina. Subretinal administration <strong>of</strong> viral vectors encoding the absent pigment, lead to<br />
a long-lasting improvement in vision perception. However optogenetic treatments are not<br />
yet st<strong>and</strong>ard in the therapy <strong>of</strong> blindness, mainly due to the fact that viral gene transfer<br />
bears many risks.<br />
9